PNC Financial Services Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$824K Buy
14,589
+719
+5% +$41.9K ﹤0.01% 1393
2025
Q4
$824K Buy
13,870
+2,613
+23% +$142K ﹤0.01% 1364
2025
Q3
$610K Buy
11,257
+510
+5% +$29.2K ﹤0.01% 1510
2025
Q2
$591K Sell
10,747
-2,069
-16% -$122K ﹤0.01% 1441
2025
Q1
$906K Buy
12,816
+650
+5% +$43.7K ﹤0.01% 1205
2024
Q4
$800K Buy
12,166
+76
+0.6% +$5.09K ﹤0.01% 1267
2024
Q3
$850K Buy
12,090
+3,122
+35% +$261K ﹤0.01% 1243
2024
Q2
$738K Buy
8,968
+1,447
+19% +$120K ﹤0.01% 1268
2024
Q1
$657K Sell
7,521
-682
-8% -$61.1K ﹤0.01% 1369
2023
Q4
$791K Sell
8,203
-116
-1% -$10.3K ﹤0.01% 1255
2023
Q3
$736K Sell
8,319
-1,509
-15% -$134K ﹤0.01% 1269
2023
Q2
$852K Sell
9,828
-1,202
-11% -$113K ﹤0.01% 1233
2023
Q1
$1.07M Sell
11,030
-162
-1% -$16.8K ﹤0.01% 1119
2022
Q4
$1.16M Sell
11,192
-443
-4% -$41.6K ﹤0.01% 1058
2022
Q3
$986K Buy
11,635
+801
+7% +$71.3K ﹤0.01% 1129
2022
Q2
$898K Buy
10,834
+2,472
+30% +$197K ﹤0.01% 1214
2022
Q1
$644K Buy
8,362
+1,055
+14% +$88.3K ﹤0.01% 1485
2021
Q4
$645K Sell
7,307
-249
-3% -$20.5K ﹤0.01% 1540
2021
Q3
$584K Buy
7,556
+881
+13% +$69.5K ﹤0.01% 1518
2021
Q2
$557K Buy
6,675
+291
+5% +$23.1K ﹤0.01% 1534
2021
Q1
$482K Sell
6,384
-2,239
-26% -$183K ﹤0.01% 1590
2020
Q4
$756K Buy
8,623
+2,481
+40% +$197K ﹤0.01% 1256
2020
Q3
$469K Sell
6,142
-118
-2% -$11.9K ﹤0.01% 1399
2020
Q2
$772K Sell
6,260
-569
-8% -$56.6K ﹤0.01% 1152
2020
Q1
$577K Buy
6,829
+1,109
+19% +$95.6K ﹤0.01% 1218
2019
Q4
$483K Sell
5,720
-25,331
-82% -$1.91M ﹤0.01% 1496
2019
Q3
$2.09M Sell
31,051
-4,553
-13% -$351K ﹤0.01% 954
2019
Q2
$3.05M Sell
35,604
-2,441
-6% -$209K ﹤0.01% 860
2019
Q1
$3.38M Sell
38,045
-3,406
-8% -$316K ﹤0.01% 855
2018
Q4
$3.53M Sell
41,451
-125
-0.3% -$11.9K ﹤0.01% 800
2018
Q3
$4.03M Sell
41,576
-1,538
-4% -$154K ﹤0.01% 823
2018
Q2
$4.06M Buy
43,114
+961
+2% +$84.2K ﹤0.01% 816
2018
Q1
$3.42M Buy
42,153
+820
+2% +$70.4K ﹤0.01% 861
2017
Q4
$3.69M Sell
41,333
-1,477
-3% -$128K ﹤0.01% 840
2017
Q3
$3.98M Sell
42,810
-646
-1% -$57.1K ﹤0.01% 786
2017
Q2
$3.95M Buy
43,456
+1,900
+5% +$173K ﹤0.01% 766
2017
Q1
$3.65M Sell
41,556
-3,939
-9% -$350K ﹤0.01% 777
2016
Q4
$3.77M Sell
45,495
-5,099
-10% -$438K ﹤0.01% 762
2016
Q3
$4.68M Buy
50,594
+3,433
+7% +$323K 0.01% 678
2016
Q2
$3.67M Sell
47,161
-5,296
-10% -$450K ﹤0.01% 721
2016
Q1
$4.33M Buy
52,457
+7,126
+16% +$580K 0.01% 672
2015
Q4
$4.75M Sell
45,331
-3,463
-7% -$362K 0.01% 633
2015
Q3
$5.14M Buy
48,794
+804
+2% +$107K 0.01% 632
2015
Q2
$6.56M Sell
47,990
-356
-0.7% -$44.1K 0.01% 613
2015
Q1
$6.03M Sell
48,346
-1,217
-2% -$129K 0.01% 639
2014
Q4
$4.48M Buy
49,563
+228
+0.5% +$19K ﹤0.01% 689
2014
Q3
$3.56M Buy
49,335
+2,596
+6% +$171K ﹤0.01% 734
2014
Q2
$2.91M Buy
46,739
+7,395
+19% +$447K ﹤0.01% 760
2014
Q1
$2.68M Sell
39,344
-1,105
-3% -$81.4K ﹤0.01% 754
2013
Q4
$2.85M Sell
40,449
-51
-0.1% -$3.46K ﹤0.01% 748
2013
Q3
$2.92M Sell
40,500
-3,480
-8% -$231K ﹤0.01% 726
2013
Q2
$2.45M Buy
+43,980
New +$2.74M ﹤0.01% 732

Other funds holding BMRN